Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.51 | 52 Week High | $1.37 | |||
| Open | $0.51 | 52 Week Low | $0.24 | |||
| Day High | $0.51 | P/E | N/A | |||
| Day Low | $0.51 | EPS | $0.00 | |||
| Volume | 26 | |||||
